Javascript must be enabled to continue!
Neuroimaging biomarkers in prodromal DLB
View through CrossRef
AbstractBackgroundPatients with dementia with Lewy bodies (DLB) are characterized by hypometabolism in the parieto‐occipital cortex and the cingulate island sign on F18‐fluorodeoxyglucose (FDG) PET, lower medial temporal F18‐Flortaucipir uptake on tau PET, and lower volumes of the basal forebrain gray matter nuclei on MRI. Whether this pattern of imaging findings is present as early as the prodromal stage of DLB is unknown. We investigated the pattern of hypometabolism, atrophy, and Flortaucipir uptake in patients with mild cognitive impairment (MCI) who progressed to DLB and compared them to MCI patients who progressed to Alzheimer’s disease dementia (ADdem).MethodPatients with MCI who underwent FDG PET (n=17), Flortaucipir PET (n=9) and MRI (n=28) at baseline and progressed to probable DLB were included. We also included a cognitively unimpaired cohort of controls and MCI patients who progressed to probable ADdem (MCI‐AD) for comparison. Voxel‐base analysis on SPM12 and region‐based analysis were performed to compare the clinical groups.ResultPatients with MCI‐DLB had profound hypometabolism in the parieto‐occipital region extending into the temporal lobes, substantia nigra and thalamus. When compared to MCI‐AD, the hippocampal and posterior cingulate metabolism were relatively preserved in patients with MCI‐DLB, accompanied by greater hypometabolism in the substantia nigra in MCI‐DLB than MCI‐AD. MCI‐DLB patients were also characterized by greater atrophy in the substantia innominata (nucleus basalis of Meynert and the diagonal band) on MRI. F‐18 Flortaucipir uptake in MCI‐DLB was comparable to the control group, but significantly lower than MCI‐AD particularly in the medial temporal lobes.ConclusionImaging biomarkers can identify neurodegenerative changes associated with the prodromal phase of DLB. Prodromal DLB patients are characterized by greater atrophy in basal forebrain nuclei, suggesting that the degeneration of the cholinergic system occur as early as the prodromal stage in DLB. Preservation of medial temporal metabolism, the cingulate island sign, and substantia nigra hypometabolism on FDG PET and lower medial temporal F18‐ Flortaucipir uptake can be used to distinguish prodromal DLB and prodromal ADdem.
Title: Neuroimaging biomarkers in prodromal DLB
Description:
AbstractBackgroundPatients with dementia with Lewy bodies (DLB) are characterized by hypometabolism in the parieto‐occipital cortex and the cingulate island sign on F18‐fluorodeoxyglucose (FDG) PET, lower medial temporal F18‐Flortaucipir uptake on tau PET, and lower volumes of the basal forebrain gray matter nuclei on MRI.
Whether this pattern of imaging findings is present as early as the prodromal stage of DLB is unknown.
We investigated the pattern of hypometabolism, atrophy, and Flortaucipir uptake in patients with mild cognitive impairment (MCI) who progressed to DLB and compared them to MCI patients who progressed to Alzheimer’s disease dementia (ADdem).
MethodPatients with MCI who underwent FDG PET (n=17), Flortaucipir PET (n=9) and MRI (n=28) at baseline and progressed to probable DLB were included.
We also included a cognitively unimpaired cohort of controls and MCI patients who progressed to probable ADdem (MCI‐AD) for comparison.
Voxel‐base analysis on SPM12 and region‐based analysis were performed to compare the clinical groups.
ResultPatients with MCI‐DLB had profound hypometabolism in the parieto‐occipital region extending into the temporal lobes, substantia nigra and thalamus.
When compared to MCI‐AD, the hippocampal and posterior cingulate metabolism were relatively preserved in patients with MCI‐DLB, accompanied by greater hypometabolism in the substantia nigra in MCI‐DLB than MCI‐AD.
MCI‐DLB patients were also characterized by greater atrophy in the substantia innominata (nucleus basalis of Meynert and the diagonal band) on MRI.
F‐18 Flortaucipir uptake in MCI‐DLB was comparable to the control group, but significantly lower than MCI‐AD particularly in the medial temporal lobes.
ConclusionImaging biomarkers can identify neurodegenerative changes associated with the prodromal phase of DLB.
Prodromal DLB patients are characterized by greater atrophy in basal forebrain nuclei, suggesting that the degeneration of the cholinergic system occur as early as the prodromal stage in DLB.
Preservation of medial temporal metabolism, the cingulate island sign, and substantia nigra hypometabolism on FDG PET and lower medial temporal F18‐ Flortaucipir uptake can be used to distinguish prodromal DLB and prodromal ADdem.
Related Results
CSF and plasma biomarkers for DLB
CSF and plasma biomarkers for DLB
AbstractBackgroundCSF biomarkers of amyloid and tau provide components of the A/T/N classification for AD and hold clinical prognostic value. They can help to identify how AD co‐pa...
Dynamic load balancing for hybrid applications
Dynamic load balancing for hybrid applications
It is well known that load imbalance is a major source of efficiency loss in HPC (High Performance Computing) environments. The load imbalance problem has very different sources, f...
Advances in dementia with Lewy bodies
Advances in dementia with Lewy bodies
Dementia with Lewy bodies (DLB) is a clinical diagnosis representing a specific presentation of a pathological α-synucleinopathy (Lewy body disease). DLB is one entity under the br...
EEG biomarkers for the early diagnosis of DLB
EEG biomarkers for the early diagnosis of DLB
AbstractBackgroundThe early detection and classification of Dementia with Lewy Bodies (DLB) are important clinical support tasks for medical practitioners in customizing patient tr...
Challenges in Predicting Cognitive Decline in Dementia with Lewy Bodies
Challenges in Predicting Cognitive Decline in Dementia with Lewy Bodies
Despite being the second most common form of neurodegenerative dementia, dementia with Lewy bodies (DLB) is under-recognized and carries a worse prognosis than other subtypes of th...
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Background and objective: Symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes t...
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Background and objective: The symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This mak...
Optimizing cCOG, a web‐based tool, to detect dementia with Lewy Bodies.
Optimizing cCOG, a web‐based tool, to detect dementia with Lewy Bodies.
AbstractBackgroundDiagnosing dementia with Lewy bodies (DLB) is challenging due to overlapping clinical and cognitive presentation with Alzheimer’s disease (AD). Web‐based cognitiv...

